PPARA and neoplasm: In the mouse model of skin carcinogenesis, an animal topicallytreated with PPARα ligands exhibited an approximately 30% lower skin tumoryield compared with mice treated with vehicle, thus indicating that the activationof PPARα may suppress the earliest stages of tumor development [92].